Core Insights - The core strategy of the company is to enhance profitability through the launch of its own brand products, which is a key component of its "upward move" plan [1] Business Strategy - The company is actively seeking deep collaborations with pharmaceutical companies to help them market products tailored to downstream demand, converting potential market opportunities into actual sales [1] - The company aims to leverage its established brand influence and channel advantages to strategically expand its own brand product offerings, focusing on high-quality products that meet diverse market needs [1] Financial Performance - For the three months ending September 30, 2025, the total transaction value of the brand launch business, including the company's own brand business, reached 658 million yuan, representing a year-on-year increase of 163.0% [1]